Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

NEW YORK, May 18, 2023 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit¬†in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed’s oral … Read more